Generation of recombinant hyperimmune globulins from diverse B-cell repertoires
-
Published:2021-04-15
Issue:8
Volume:39
Page:989-999
-
ISSN:1087-0156
-
Container-title:Nature Biotechnology
-
language:en
-
Short-container-title:Nat Biotechnol
Author:
Keating Sheila M.ORCID, Mizrahi Rena A.ORCID, Adams Matthew S., Asensio Michael A.ORCID, Benzie Emily, Carter Kyle P., Chiang Yao, Edgar Robert C., Gautam Bishal K.ORCID, Gras Ashley, Leong Jackson, Leong Renee, Lim Yoong WearnORCID, Manickam Vishal A., Medina-Cucurella Angelica V., Niedecken Ariel R., Saini Jasmeen, Simons Jan Fredrik, Spindler Matthew J., Stadtmiller Kacy, Tinsley BrendanORCID, Wagner Ellen K., Wayham Nicholas, Tracy LaRee, Lundberg Carina Vingsbo, Büscher Dirk, Terencio Jose Vicente, Roalfe Lucy, Pearce Emma, Richardson Hayley, Goldblatt DavidORCID, Ramjag Anushka T., Carrington Christine V. F.ORCID, Simmons Graham, Muench Marcus O.ORCID, Chamow Steven M., Monroe Bryan, Olson Charles, Oguin Thomas H., Lynch Heather, Jeanfreau Robert, Mosher Rachel A., Walch Matthew J., Bartley Christopher R., Ross Carl A., Meyer Everett H., Adler Adam S.ORCID, Johnson David S.ORCID
Funder
National Science Foundation U.S. Department of Health & Human Services | National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference48 articles.
1. Bozzo, J. & Jorquera, J. I. Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role. Expert Rev. Anti Infect. Ther. 15, 585–604 (2017). 2. Beasley, R. P. et al. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology. 3, 135–141 (1983). 3. Payne, J. R., Khouri, J. M., Jewell, N. P. & Arnon, S. S. Efficacy of human botulism immune globulin for the treatment of infant botulism: the first 12 years post licensure. J Pediatr. 193, 172–177 (2018). 4. Gaber, A. O. et al. Results of the double-blind, randomized, multicenter, phase III clinical trial of thymoglobulin versus atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation. 66, 29–37 (1998). 5. Branche, E. et al. Human polyclonal antibodies prevent lethal Zika virus infection in mice. Sci. Rep. 9, 9857 (2019).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|